CCDC127 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that targets a wide range of kinases. Inhibition of these kinases can prevent phosphorylation events that are essential for CCDC127 function and interaction with other proteins, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A specific inhibitor of phosphoinositide 3-kinases (PI3K). PI3K signaling is crucial for many cellular processes, and by inhibiting this pathway, downstream effects on the actin cytoskeleton may occur, which can indirectly inhibit CCDC127's cellular functions if they are reliant on actin dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that disrupts the mTOR signaling pathway, which is involved in cell growth and proliferation. By inhibiting mTOR, the cellular context in which CCDC127 operates could be altered, leading to a decrease in its functional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that changes chromatin structure and gene expression. Although not directly affecting CCDC127, the altered gene expression could influence the cellular pathways and functions CCDC127 is involved in, thus indirectly inhibiting its functional activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin. By inhibiting calcineurin, Cyclosporin A can alter T-cell activation pathways, potentially affecting CCDC127's role if it is involved in immune cell function or signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor similar to Wortmannin, which can also lead to alterations in the actin cytoskeleton and affect cellular functions that CCDC127 may be a part of, thereby indirectly inhibiting its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which is a part of the MAPK/ERK pathway. By inhibiting MEK, PD 98059 can downregulate the MAPK/ERK signaling, potentially impacting the regulatory environment of CCDC127 and its associated cellular processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of ADP-ribosylation factor (ARF), which is involved in vesicle trafficking. Disruption of vesicle trafficking could impact the localization and function of CCDC127 if it is associated with such processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of both MEK1 and MEK2, which are upstream of ERK in the MAPK pathway. U0126's inhibition of this pathway can have downstream effects on cellular functions that CCDC127 may be involved with, leading to its inhibition. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor that mimics glucose but cannot be fully utilized in the glycolytic pathway, leading to energy depletion in the cell. If CCDC127's function is energy-dependent, this energy depletion could result in the inhibition of its activity. | ||||||